Using the Alpha-P1 Glassia treatment from Israel’s Kamada, sufferers of inherited emphysema can reduce the weekly time taken for infusions down from 70 minutes to just 15. It greatly improves their quality of life.
http://finance.yahoo.com/news/kamada-announces-significantly-improved-infusion-120000356.html
Reduced treatment times for Emphysema patients
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.